Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?

about

Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis

P2860

Q58252419-4FFB1A84-1384-479F-8C38-2D080B85F3FB

P2860

Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?

Item

http://www.wikidata.org/entity/Q40805808

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Can echocardiography and ECG d ...... m hypertrophic cardiomyopathy?

@en

type

Item

label

Can echocardiography and ECG d ...... m hypertrophic cardiomyopathy?

@en

prefLabel

Can echocardiography and ECG d ...... m hypertrophic cardiomyopathy?

@en

P1476

Can echocardiography and ECG d ...... m hypertrophic cardiomyopathy?

@en

P2093

Christer Grönlund

http://www.w3.org/2001/XMLSchema#string

Gabriel Granåsen

http://www.w3.org/2001/XMLSchema#string

Michael Henein

http://www.w3.org/2001/XMLSchema#string

Per Lindqvist

http://www.w3.org/2001/XMLSchema#string

Sandra Gustavsson

http://www.w3.org/2001/XMLSchema#string

P2860

Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP)

Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

Current perspectives on cardiac amyloidosis.

The molecular biology and clinical features of amyloid neuropathy.

Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Infiltrative cardiovascular diseases: cardiomyopathies that look alike.

Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography.

Quantitative texture analysis in two-dimensional echocardiography: application to the diagnosis of myocardial amyloidosis.

P304

163-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13506129.2015.1037831

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ole B. Suhr

Urban Wiklund

Stellan Mörner

P577

2015-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26104852

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?

about

P2860

P2860

Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921